Flipping a molecular switch
HIRI and University of Cambridge shed light onto an essential protein-assisted genetic switch in Cardioviruses
Researchers from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Cambridge have revealed the molecular details of a genetic switch through their work on the 2A protein of cardioviruses. Using a new RNA-binding fold, the 2A protein activates a process called ribosomal frameshifting, which allows the virus to replicate more efficiently. This event represents an essential switch in the life cycle of the virus as well as presenting a viral Achilles‘ heel that could be targeted by future RNA-based therapies. The new findings have been published in the journal Nature Communications. The HIRI is a joint venture of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Julius Maximilian University of Würzburg (JMU)
Infections with the encephalomyocarditis virus (EMCV) affect a variety of mammals such as pigs and chimpanzees. However, humans can also become infected, resulting in fever and inflammatory disease. Like other cardioviruses – or like the highly infectious coronavirus SARS-CoV-2 – EMCV is an RNA virus: its genetic material consists of ribonucleic acid (RNA). Since viruses do not have their own metabolism, in order to reproduce they must infect a host cell and take control over its protein synthesis factories: ribosomes.
A forced error: protein-modulated frameshifting
The manipulation of the host cell’s protein factory is achieved by ribosomal frameshifting: When reading and translating the genetic information in the messenger RNA, a proportion of ribosomes are forced into a new reading frame. This changes the way the entire sequence is decoded and allows more than one protein to be synthesized from a single messenger RNA.
„By hijacking the host’s translation engine and corrupting the system to produce their own proteins, viruses have proven to be fearsome cellular invaders,“ says Jun Prof Neva Caliskan, research group leader at the Würzburg Helmholtz Institute for RNA-based Infection Research (HIRI) and co-corresponding author of the study.
„In our current work, we focused on investigating how this process is regulated in EMCV replication. The multifunctional 2A protein has a key role in this process,“ says Prof Ian Brierley, group leader at the University of Cambridge (Department of Pathology) and co-corresponding author of the study.
Scientists at the University of Cambridge have solved the crystal structure of 2A and revealed how it interacts with ribosomes by cryo-EM. Dr Chris Hill, one of the leading authors of the study and now a new group leader at the University of York, explains “the fold of this protein doesn’t resemble any other known RNA-binding proteins, so we call it the ‘beta-shell’. With these structural blueprints, we can better understand years of previous work on how this multi-functional protein can interact with its targets.”
Researchers were also able to show how this folding contributes to the interactions of 2A with the viral RNA. „The docking of the 2A protein to the RNA stabilizes its structure and forces a frameshift,“ explains Lukáš Pekárek, who is one of the first authors of the scientific study. „We were able to observe this effect in detail, at high resolution through our optical tweezers,“ says the HIRI PhD student in the Caliskan lab.
„At the beginning of an EMCV infection, the 2A protein is not yet present; instead, other proteins that the virus needs to replicate its genome are active,“ says HIRI PhD student Anuja Kibe, who also contributed to the study. As the infection progresses, she says, 2A accumulates in the cells and stimulates the frameshift. With that, the pathogen can finely adjust the amounts of different proteins required to assemble more viruses.
Further research can address this viral Achilles‘ heel to develop targeted RNA technologies and therapeutics and bring them into medical use.
Cardioviruses are among the smallest viruses in the world. They have a diameter of about 22 to 30 nanometres, approximately a thousand times smaller than the diameter of a hair. This is far too small to visualize viruses of this size under a light microscope. RNAs, or ribonucleic acids, which make up the genome of these viruses, are even smaller. Scientists at HIRI therefore work with single molecule optical tweezers, among other cutting-edge technologies. These make it possible to examine molecular structures and RNA functions in atomic resolution.
The study was supported by funding from the Wellcome Trust, the Helmholtz Association and the European Research Council, among others.
This press release is also available on our homepage: https://www.helmholtz-hzi.de/en/news-events/news/view/article/complete/einfach-mal-den-schalter-umlegen/
Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and its other sites in Germany are engaged in the study of bacterial and viral infections and the body’s defence mechanisms. They have a profound expertise in natural compound research and its exploitation as a valuable source for novel anti-infectives. As member of the Helmholtz Association and the German Center for Infection Research (DZIF) the HZI performs translational research laying the ground for the development of new treatments and vaccines against infectious diseases. https://www.helmholtz-hzi.de/en
The Helmholtz Institute for RNA-based Infection Research:
The Helmholtz Institute for RNA-based Infection Research (HIRI) was founded in May 2017. It is a joint institution of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Julius-Maximilians-Universität Würzburg (JMU). Based on the University hospital campus, the HIRI is the first federal institute to focus on the role of ribonucleic acids (RNAs) in infection processes. Its mission is to combine basic research with the development of new RNA-centric therapeutic approaches to treat infections. https://www.helmholtz-hiri.de
Dr. Britta Grigull
Presse & Public Relations
Hill C H, Pekárek L, Napthine S, Kibe A, Firth A E, Graham S C, Caliskan N, Brierley I. Structural and molecular basis for Cardiovirus 2A protein as a viral gene expression switch. Nature Communications, Dec. 9, 2021. DOI: 10.1038/s41467-021-27400-7